Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Mylan agrees to pay $335 million over nine years to settle claims of misleading opioid marketing.

flag Pharmaceutical company Mylan Inc., now part of Viatris, has agreed to pay $335 million over nine years to settle allegations of misleading marketing of its opioid products, which were falsely promoted as less prone to abuse. flag The settlement, involving multiple states, aims to fund addiction treatment and prevention services. flag States like Oregon and Virginia expect to receive millions to combat the opioid crisis.

12 Articles

Further Reading